Discussione tra esperti
Priorità all’OCT nel periodo post COVID-19
10 giugno 2020
· 50 MIN VISIONE
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/dr-ike-ahmed.jpg/_jcr_content/renditions/original.image_file.100.100.file/dr-ike-ahmed.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/dr-ike-ahmed.jpg/_jcr_content/renditions/original.image_file.360.360.file/dr-ike-ahmed.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/dr-ike-ahmed.jpg/_jcr_content/renditions/original.image_file.768.768.file/dr-ike-ahmed.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/dr-ike-ahmed.jpg/_jcr_content/renditions/original.image_file.1024.1024.file/dr-ike-ahmed.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/dr-ike-ahmed.jpg/_jcr_content/renditions/original./dr-ike-ahmed.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/dr-ike-ahmed.jpg/_jcr_content/renditions/original./dr-ike-ahmed.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/dr-ike-ahmed.jpg/_jcr_content/renditions/original./dr-ike-ahmed.jpg"})
Autore
Ike Ahmed, MD
Prism Eye Institute, Canada
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/schlenker-m.jpg/_jcr_content/renditions/original.image_file.100.100.file/schlenker-m.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/schlenker-m.jpg/_jcr_content/renditions/original.image_file.360.360.file/schlenker-m.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/schlenker-m.jpg/_jcr_content/renditions/original.image_file.768.768.file/schlenker-m.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/schlenker-m.jpg/_jcr_content/renditions/original.image_file.1024.1024.file/schlenker-m.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/schlenker-m.jpg/_jcr_content/renditions/original./schlenker-m.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/schlenker-m.jpg/_jcr_content/renditions/original./schlenker-m.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/schlenker-m.jpg/_jcr_content/renditions/original./schlenker-m.jpg"})
Autore
Matt Schlenker, MD
Kensington Eye Institute, Canada
RIEPILOGO
Utilizzo e priorità all’OCT per la gestione del glaucoma nel periodo post COVID-19
Questa utile discussione vede la partecipazione degli esperti Ike Ahmed, MD e Matt Schlenker, MD, che condividono le loro idee su come gestire al meglio i pazienti affetti da glaucoma e dare la priorità all’OCT nel periodo post COVID-19. Questo momento storico è caratterizzato da code di pazienti da smaltire, i quali tornano in ambulatorio per visite o esami da svolgere di persona. Per questo, gli esperti consigliano di considerare 4 fattori:
- Come valutare i pazienti affetti da glaucoma con la teleoftalmologia
- Scoprire come assegnare valutazioni nel modo più efficiente possibile, utilizzando l’imaging e tenendo conto della correlazione struttura-funzione
- Sfruttare le singole stampe per la valutazione della patologia e l’identificazione degli artefatti
- Il valore dell’analisi della progressione nel periodo post COVID-19